Clik here to view.
Sosei Heptares raises $200m to drive growth initiatives
Sosei Group Corporation, which has major research facilities in Cambridge, has raised $200 million global growth capital through an international offering.The majority of funds will be used to pursue...
View ArticleClik here to view.
AstraZeneca reveals advance in COVID-19 vaccine trials
Cambridge Big Biotech AstraZeneca is upbeat about the latest feedback from trials of the new Oxford University vaccine designed to wipe out COVID-19.Interim results from the ongoing Phase I/II COV001...
View ArticleClik here to view.
DisplayLink sold for $305m cash to Synaptics in deal valued at $407m
World leading semiconductor and software technology company DisplayLink has effected one of the most remarkable turnarounds in Cambridge corporate history with a $305 million cash sale to US company...
View ArticleClik here to view.
Making the most of R&D tax credits in the farming industry
Farmers in the UK are missing out on millions of pounds worth of Research & Development (R&D) tax credits every year, with the average cashback claimed by SMEs in the Farming, Forestry and...
View ArticleClik here to view.
Could data protection concerns derail the test and trace app?
When the UK launched its test and trace program on 28 May, it was missing a key element; the test and trace app developed by NHSX, writes Kitty Rosser – senior associate at East of England law firm...
View ArticleClik here to view.
Abcam explores US IPO
Cambridge life science innovator Abcam plc is exploring the possibility of an IPO on NASDAQ, the US technology market.It would supplement the company’s current listing in the UK and widen a trail from...
View ArticleClik here to view.
Smart money on a $47bn Nvidia bid for Arm
US technology giant Nvidia Corporation could pay up to $47 billion for Cambridge UK superchip world leader Arm, Business Weekly believes.Serial technology entrepreneurs contacted by Business Weekly...
View ArticleClik here to view.
AstraZeneca agrees potential $6bn oncology deal with Daiichi Sankyo
Cambridge UK Big Biotech AstraZeneca has slated a deal that could stack up to $6 billion with Daiichi Sankyo, Japan’s second largest Big Pharma company, to transform treatment standards in lung, breast...
View ArticleClik here to view.
Talking heads: Cambridge startup pioneers holographic headset
VividQ, a deep tech software startup based in Cambridge, has received a Smart Grant of £334K from Innovate UK to fund groundbreaking industrial R & D for a world first holographic headset...
View ArticleClik here to view.
Horizon Discovery revives US public offering push
Cambridge-based gene editing world leader Horizon Discovery has decided to resuscitate plans for an initial US public offering of American depositary shares.The company believes the time is ripe after...
View ArticleClik here to view.
F-star Therapeutics gets NASDAQ listing via US merger
Cambridge UK life science business F-star Therapeutics is merging with US-listed Spring Bank Pharmaceuticals in Massachusetts.On completion of the deal F-star’s CEO, Eliot Forster, will become...
View ArticleClik here to view.
Technology clusters – it’s good to share!
I am sure that most of us can remember our parents telling us to share our toys or sweets with another child, writes Andrew Priest, a partner in the Corporate and Commercial team at law firm Birketts...
View ArticleClik here to view.
Science and tech companies must max their own talent to thrive in new trading...
The UK would like to apologise if it has failed to wreck relationships with any of the world’s leading trade powers. Oversights can happen.Now estranged from the EU with potentially disastrous...
View ArticleClik here to view.
Argos goes totally digital: Is this the final page for print?
Do you remember football pools, Green Shield Stamps and Christmas Clubs – those quaintly old-fashioned ways in which our grans and grandads saved or squandered their money? All gone – replaced by the...
View ArticleClik here to view.
Frontier breaks $billion valuation barrier
Frontier Developments, the Cambridge-based world-leading video games developer, has three times topped the magical $billion valuation in the space of a month.While only privately held startups qualify...
View ArticleClik here to view.
Sosei Heptares plots blockbusting acquisition
Global biopharma group Sosei Heptares, which has European research operations in the Cambridge UK science & technology cluster, is plotting what it says will be a potentially transformative...
View ArticleClik here to view.
Marshall Motor Holdings gears up for fresh acquisitions
Quoted Cambridge company Marshall Motor Holdings is using its UK market leading position and substantial war chest to identify potential fresh acquisitions and swoop when the time is ripe.CEO Daksh...
View ArticleClik here to view.
Meat from animal cells pioneer raises ‘steaks’ with relocation to Cambridge
The global pull of the Cambridge life science cluster has prompted a UK startup growing meat products from animal cells to move its HQ here from Bristol as it chases a slice of a $1.4 trillion meat...
View ArticleClik here to view.
Tax-advantaged investment schemes
Successive governments have recognised business funding reliefs as a valuable means of encouraging investment into technology companies, writes James Francis, partner at Ensors Chartered Accountants....
View ArticleClik here to view.
Sorex raises £900k and boosts top team to hit $323bn sensors market
Cambridge University spin-out Sorex Sensors has raised £900,000 to fund further development of its novel sensor technology and target a global market tipped to be worth $323 billion inside four...
View Article